As of January 22, 2025, Inozyme Pharma (INZY) has a market cap of $83.512 million USD. According to our data, Inozyme Pharma is ranked No.7823 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $83.51 M |
-53.07%
|
Dec 31, 2024 | $0.18 B |
-34.98%
|
Dec 29, 2023 | $0.27 B |
305.71%
|
Dec 30, 2022 | $67.45 M |
-84.60%
|
Dec 31, 2021 | $0.44 B |
-66.96%
|
Dec 31, 2020 | $1.33 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
BioMarin Pharmaceutical
BMRN
|
$11.82 B |
0.000 M
|
USA
|
Ultragenyx
RARE
|
$3.97 B |
0.000 M
|
USA
|
Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
Vertex Pharmaceuticals
VRTX
|
$110.22 B |
0.001 M
|
USA
|
CRISPR Therapeutics
CRSP
|
$3.77 B |
-0.000 M
|
Switzerland
|
Editas Medicine
EDIT
|
$0.11 B |
-0.000 M
|
USA
|
Intellia Therapeutics
NTLA
|
$1.12 B |
0.000 M
|
USA
|
Sangamo Therapeutics
SGMO
|
$0.24 B |
-0.000 M
|
USA
|
bluebird bio
BLUE
|
$76.22 M |
0.000 M
|
USA
|
Moderna
MRNA
|
$14.82 B |
-0.000 M
|
USA
|
Alnylam Pharmaceuticals
ALNY
|
$34.38 B |
-0.000 M
|
USA
|
Sarepta Therapeutics
SRPT
|
$11.09 B |
0.000 M
|
USA
|
Ionis Pharmaceuticals
IONS
|
$5.13 B |
-0.000 M
|
USA
|
Market Cap | = | INZY Stock Price | * | INZY Shares Outstanding |
= | $1.30 | * | 64.24 M | |
= | $83.51 M |